Proteomic screening and functional investigation of E3 ubiquitin ligase substrate-adapter KLHL6 reveal a new role targeting B-cell receptor, which is disrupted in a subset of B-cell lymphomas with targetable phenotypic characteristics. The gene discussed is KLHL6; the disease is B-cell non-Hodgkin lymphoma.